Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Castration-Resistant Prostate Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more
Exelixis 1,394
Early research (Phase 1)Looking for participantsNCT06966024
What this trial is testing

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Who this might be right for
Renal Cell CarcinomaUrothelial CarcinomaCastration-resistant Prostate Cancer
Deciphera Pharmaceuticals, LLC 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02312557
What this trial is testing

Pembrolizumab in Treating Patients With Metastatic Castration Resistant Prostate Cancer Previously Treated With Enzalutamide

Who this might be right for
Castration-Resistant Prostate CarcinomaHormone-Resistant Prostate CancerPSA Progression+2 more
OHSU Knight Cancer Institute 58
Testing effectiveness (Phase 2)Looking for participantsNCT05113537
What this trial is testing

Abemaciclib Before 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IV Prostate Cancer AJCC v8+4 more
Vadim S Koshkin 30
Testing effectiveness (Phase 2)Looking for participantsNCT06844383
What this trial is testing

Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide

Who this might be right for
Prostate Cancer (Adenocarcinoma)mCRPC (Metastatic Castration-resistant Prostate Cancer)
Prostate Cancer Clinical Trials Consortium 126
Early research (Phase 1)Ended earlyNCT01913015
What this trial is testing

Dietary Fat Levels and Abiraterone Acetate Uptake in Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
OHSU Knight Cancer Institute 3
Testing effectiveness (Phase 2)Looking for participantsNCT07179783
What this trial is testing

Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Castration-ResistantProstate Adenocarcinoma With Neuroendocrine Differentiation
Tianjin Medical University Second Hospital 28
Testing effectiveness (Phase 2)Looking for participantsNCT07698535
What this trial is testing

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

Who this might be right for
Metastatic Castration-Resistant Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
University of Washington 64
Early research (Phase 1)Active Not RecruitingNCT04514484
What this trial is testing

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

Who this might be right for
Advanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more
National Cancer Institute (NCI) 8
Early research (Phase 1)Active Not RecruitingNCT03845166
What this trial is testing

XL092 as Single-Agent and Combination Therapy in Subjects With Solid Tumors

Who this might be right for
Neoplasm MalignantRenal Cell CarcinomaHormone Receptor Positive Breast Carcinoma+2 more
Exelixis 325
Early research (Phase 1)Ended earlyNCT02963051
What this trial is testing

A Phase Ib Study of Intravenous Copper Loading With Oral Disulfiram in Metastatic, Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Daniel George, MD 9
Testing effectiveness (Phase 2)Study completedNCT03888612
What this trial is testing

Trial of ARV-110 in Patients With Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Arvinas Inc. 248
Testing effectiveness (Phase 2)Study completedNCT03456804
What this trial is testing

ESK981 in Treating Patients With Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Barbara Ann Karmanos Cancer Institute 13
Testing effectiveness (Phase 2)Looking for participantsNCT05919264
What this trial is testing

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Who this might be right for
CancerColorectal CancerSolid Tumor+12 more
Parabilis Medicines, Inc. 619
Testing effectiveness (Phase 2)Looking for participantsNCT06582628
What this trial is testing

Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)

Who this might be right for
Metastatic Prostate Cancer
Fundacion Oncosur 78
Early research (Phase 1)Ended earlyNCT04249947
What this trial is testing

P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)

Who this might be right for
Prostatic Neoplasms, Castration-ResistantNeoplasms by Histologic TypeNeoplasms, Prostate+14 more
Poseida Therapeutics, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT02987829
What this trial is testing

Phase 1/2A Study of TRC253, an Androgen Receptor Antagonist, in Metastatic Castration-resistant Prostate Cancer Patients

Who this might be right for
Metastatic Castrate-resistant Prostate CancerAdenocarcinoma, Prostate
Tracon Pharmaceuticals Inc. 72
Early research (Phase 1)Study completedNCT03829436
What this trial is testing

TPST-1120 as Monotherapy and in Combination With Nivolumab in Subjects With Advanced Cancers

Who this might be right for
Hepatocellular CarcinomaMetastatic Castration Resistant Prostate CancerRenal Cell Carcinoma+9 more
Tempest Therapeutics 38
Testing effectiveness (Phase 2)Looking for participantsNCT06039371
What this trial is testing

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study

Who this might be right for
Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
University of Washington 69
Testing effectiveness (Phase 2)Looking for participantsNCT07038304
What this trial is testing

The Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)

Who this might be right for
Prostate Cancer (Adenocarcinoma)OligoProgressive Metastatic DiseaseCastration Resistant Metastatic Prostate Cancer+1 more
University Medical Center Groningen 35
Next Page